Home > Insider Trading > Filing (0001415889-18-000976)

Filing Details

Accession Number:: 0001415889-18-000976
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-06-20 18:20:22
Reporting Period:: 2018-06-18

Accepted Time:: 2018-06-20 18:20:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1494891	Sensus Healthcare Inc.	SRTS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1351380	Arthur Levine	851 Broken Sound Parkway Nw Ste 215 Boca Raton FL 33487	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2018-06-18	527	$7.52	203,596	No	4	S	Direct
Common Stock	Disposition	2018-06-19	247	$7.57	203,349	No	4	S	Direct
Common Stock	Disposition	2018-06-20	454	$7.52	202,895	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.57. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.64. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.65. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.